Medical event profiling of COPD patients

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 8, 2004, Pages 547-555

  Hansell, A L ^a   Lam, K A ^a   Richardson, S ^a   Visick, G ^b   Soriano, J B ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Cluster analysis; Comorbidity; COPD; Epidemiologic methods; General Practice Research Database; Logistic models

Indexed keywords

AGED; ARTICLE; CANCER RISK; CHLAMYDIASIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLASSIFICATION; CLUSTER ANALYSIS; COMORBIDITY; CONSULTATION; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; FACTUAL DATABASE; FEMALE; GENERAL PRACTICE; HEART DISEASE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; LUNG CIRCULATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MYCOSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RESPIRATORY TRACT DISEASE; RISK REDUCTION; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; UNITED KINGDOM; VIRUS INFECTION;

AGED; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; COMORBIDITY; DATABASES, FACTUAL; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; LOGISTIC MODELS; MALE; PHARMACOEPIDEMIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERRAL AND CONSULTATION;

EID: 4544225732     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.931     Document Type: Article

References (19)

1. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Safe 2001; 10: 483-486.
2. Rodriguez EM, Graham DJ. The role of databases in drug post-marketing surveillance. Pharmacoepidemiol Drug Safe 2001; 10: 407-410.
3. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995; 39(3): 223-226.
4. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary diseases. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
5. Soriano JB, Maier WC, Egger P, et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 780-794.
6. Comptom CH, Gubb J, Nieman R, et al. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. Lancet 2001; 358: 265-270.
7. Vincken W, van Noord JA, Greefhorst APM, et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19(2): 209-216.
8. Strachan D, Hansell A, Hollowell J, McNiece R, Nichols T, Anderson HR. Collation and comparison of data on respiratory disease. Report to the Department of Health. Department of Health, London, 1999. Available at http://www.sghms.ac.uk/depts/laia/COLLATE/respdata.htm [6 October 2003].
9. Everitt BS, Dunn G. Applied Multivariate Data Analysis. Edward Arnold: London, 1991.
10. Brieman L, Friedman JH, Olshen RA, Stone CJ. Classification and Regression Trees. Wadsworth and Brooks: Monterey, CA, 1984.
11. Chambers JM, Hastie TJ. Statistical Methods in S. Wadsworth and Brooks Cole Advanced Books: Pacific Grove, CA, 1992.
12. Keith RL, Cohen AJ, Miller YE. From COPD to lung cancer. In Chronic Obstructive Lung Disease, Voelkel NF, MacNee W (eds). Dekker Inc: Hamilton, BC, 2002; 403-417.
13. Hand DJ, Adams NM, Bolton RJ. Pattern Detection and Discovery: ESF Exploratory Workshop. London, UK, 16-19 September 2002. Springer Verlag: Berlin, 2003.
14. Hand DJ, Mannita H, Smyth P. Principles of Data Mining (Adaptive Computation and Machine Learning). The MIT Press: Cambridge, Massachusetts, 2001.
15. Fleming DM, Crombie DL, Cross KW. Disease concurrence in diabetes mellitus: a study of concurrent morbidity over 12 months using diabetes mellitus as an example. J Epidemiol Community Health 1991; 45: 73-77.
16. Duh M-S, Walker AM, Pagano M, Kronlund K. Prediction and cross-validation of neural networks versus logistic regression. Am J Epidemiol 1998; 147(4): 407-413.
17. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17(19): 2265-2281.
18. Cepeda MS. Editorial: the use of propensity scores in pharmacoepidemiological research. Pharmacoepidemiol Drug Safe 2000; 9: 103-104.
19. Clayton D, Hills M. Comparison of odds within strata. In Statistical Models in Epidemiology, Clayton D, Hills M (eds). Oxford University Press: Oxford, 1993; 175-185.